INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG UNCLASSIFIED/ PASS TO OFFICE CODES: FM CNO WASHINGTON DC//N1// SUBJ/INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG TESTING PANEL - PROGRAM GUIDANCE:
UNCLASSIFIED//
ATTENTION INVITED TO
ROUTINE
R 302132Z DEC 13 PSN 840295K28
FM CNO WASHINGTON DC
TO NAVADMIN
INFO ZEN/CNO WASHINGTON DC
BT
UNCLAS
SUBJ: INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG
UNCLASSIFIED/
PASS TO OFFICE CODES:
FM CNO WASHINGTON DC//N1//
TO NAVADMIN
INFO CNO WASHINGTON DC//N1//
UNCLAS N05355//
NAVADMIN 334/13
MSGID/GENADMIN/CNO//
WASHINGTON DC/N1/DEC//
SUBJ/INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG TESTING PANEL -
PROGRAM GUIDANCE//
REF/A/DOC/MEMO/25OCT13/NOTAL//
REF/B/DOC/OPNAVINST/4JUN09//
NARR/REF A IS UNDER SECRETARY OF DEFENSE (PERSONNEL AND READINESS) MEMORANDUM
UPDATE TO THE DEPARTMENT OF DEFENSE DRUG TESTING PANEL.
REF B IS OPNAVINST 5350.4D, NAVY ALCOHOL AND DRUG ABUSE PREVENTION AND
CONTROL.//
RMKS/1. Per ref (a), this NAVADMIN announces navy drug screening labs (NDSL)
will add synthetic cannabinoids (SC), also referred to as "spice", "K-2", or
"herbal incense", to the standard testing panel for urinalysis samples
submitted for testing. Samples submitted to NDSLS for regular urinalysis
testing will be tested for SC. Any Sailor whose urinalysis sample is
determined to be positive for SC may be considered in violation of the
Uniform Code of Military Justice, Article 112A For Drug Misuse/Abuse and
subject to administrative and disciplinary actions. Those Sailors found to
be drug dependent will be offered treatment prior to their separation, if
eligible.
2. Probable cause and command-directed premise code testing, as defined in
ref (b), still require authorization from Navy Alcohol and Drug Abuse
Prevention Office (OPNAV N170A) before submitting urinalysis samples to Armed
Forces Medical Examiner Services. Guidance for authorization testing is
available in the Synthetic Drug Urinalysis Operating Guide at
www.nadap.navy.mil.
3. Point of contact is Ms. Lanorfeia Parker, Navy Alcohol and Drug Abuse
Prevention Office, at 901-874-4249/DSN 882-4249, 901-481-6295, OR via e-mail
at lanorfeia.parker@navy.mil.
4. Released by Vice Admiral W. F. Moran, N1.//
BT
#1201
NNNN
UNCLASSIFIED//